SCHEMBL32662296

SCHEMBL32662296

CC1N(C)c2cccnc2N1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ PTPN2 P17706 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GPR3 P46089 1/20 0.32
▸ HTR2A P28223 2/20 0.32
▸ HTR2C P28335 2/20 0.32
▸ HTR2B P41595 2/20 0.32
▸ MYC P01106 2/20 0.32
▸ TNKS2 Q9H2K2 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16722857 1.00 KDM4E (0.47) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL26275270 1.00 KDM4E (0.47) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL23059121 0.83 ADORA3 (0.36) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16709180 0.83 KDM4E (0.39) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL23059124 0.83 KDM4E (0.39) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16709181 0.83 ADORA3 (0.36) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16709147 0.82 ADORA3 (0.35) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL22370040 0.82 ADORA3 (0.35) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16709166 0.82 KDM4E (0.38) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL22370039 0.80 KDM4E (0.37) KDM4EALDH1A1GAAHPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) 2026-01-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF WRN, MSH2, MSH6 KDM4E 2068/4885ALDH1A1 1151/4885GAA 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback